Streamlining Tech Transfer
Reducing delays and risk during scale-up and site transitions
Technology transfer remains one of the most critical—and often underestimated—steps in biologics manufacturing. Whether moving from development to clinical supply, scaling to commercial production, or transitioning between sites and CDMOs, delays at this stage can add months to launch timelines and significantly increase costs.
Critical success factors for efficient tech transfer:
- Early alignment on documentation: Process descriptions, batch records, and analytical methods should be standardized and transferred in harmonized formats to reduce rework.
- Digital knowledge management: Cloud-based data rooms and standardized templates help ensure seamless handovers across global sites.
- Risk-based approach to comparability: Not every parameter requires exhaustive testing—focus on those tied directly to critical quality attributes (CQAs).
- Cross-functional transfer teams: Bringing QA, MSAT, supply chain, and regulatory experts into the transfer plan from the beginning prevents late surprises.
- Pilot and scale-down models: Reliable laboratory-scale models allow issues to be identified and solved before full-scale production.